Science Custom Publishing
Science Custom Publishing
Podcast Description
Hear from some of the greatest minds in science on a range of topics in conversation with editors from Science custom publishing.
Podcast Insights
Content Themes
The podcast delves into various topics related to advancements in biotechnology and oncology, with episodes focusing on innovations such as gene editing, the specifics of cell therapy for solid tumors, and the implications of these technologies for patient care, exemplified by conversations around AstraZeneca's efforts in this field.
Hear from some of the greatest minds in science on a range of topics in conversation with editors from Science custom publishing.
Artificial intelligence (AI) is no longer a futuristic vision in drug discovery. It’s rapidly transforming every stage of the process, from uncovering disease biology to designing new molecules and optimizing clinical trials. In this podcast from the Science/AAAS Custom Publishing Office and sponsored by AstraZeneca, Senior Editor Erika Berg interviews AstraZeneca’s Chief Data Scientist and Vice President Data Science & AI,
BioPharmaceuticals R&D, Jim Weatherall and Stanford University’s Professor of Bioengineering, Genetics, Medicine and Biomedical Data, Russ Altman, on how AI is revolutionizing the way we discover and deliver potentially life-saving therapies. With bespoke AI tools now embedded in research and development, scientists can generate novel insights to help accelerate therapeutic development.
But this revolution isn’t happening in a vacuum. Weatherall and Altman delve into why collaboration between academia and industry is essential
for accelerating innovation while maintaining scientific rigor, ethical
safeguards, and a human-centered approach. They discuss how trust,
transparency, and a shared mission are shaping a new collaborative model, one that can drive faster, smarter, and more equitable medical breakthroughs in the age of AI.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.